| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5928319 | American Heart Journal | 2010 | 8 Pages |
Abstract
LOWERING-IT trial established that the proposed LOW-INR target is safe and feasible in low-risk patients after bileaflet aortic mechanical valve replacement. It results in similar thrombotic events and in a significant reduction of bleeding occurrence when compared to the conventional anticoagulation regimen.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michele MD, PhD, Daniele MD, PhD, Paolo MSc, Marco MD, Giampaolo MD, Luca MD, Marisa MD, PhD, Cristiano MD, Ferdinando C. MD, Teresa MD, Georgina M. PhD, Ciro MD, Maurizio MD, Gianantonio MD,